Save money and time, get standardized analysis. One of the broadest coverage of EU markets. Our key value proposition is provision of high quality pan-European support
Analyses from the same vendor for 19 different EU countries
We will help you navigate through the challenges of reimbursement and funding for medical devices and in-vitro diagnostics in Europe
MTRC is an ISO 9001:2015 certified provider of Pan-European reimbursement services and products for Med Tech and IVD industry
MTRC is a unique provider of Pan-European reimbursement services and products for Med Tech and IVD industry
Scope
Coding, payment mechanism, reimbursement tariffs, pathway to create or improve reimbursement situation
Project-based on-demand work or >95 off-the-shelf syndicated reports
Countries
19 EU
Availability
Mixed
Scope
Seminars on introduction into market access for medical devices and IVD tests, seminars on reimbursement systems in individual countries (>70 reports)
Syndicated analytical reports on the topics of HTA, innovation funding, reimbursement of health apps
Countries
19 EU
Availability
Off-the-shelf
Scope
Subscription service with email alerts about initiated or published health technology assessments and reimbursement decisions for medical devices and in-vitro diagnostic tests from reimbursement (EU) and HTA (global) organizations
Countries
24 countries globally
Availability
On-demand
Scope
Procedure code and DRG change applications in the Nordic region
Countries
Nordics
Availability
On-demand
Scope
A fact-based, unbiased approach to determine clinical and economic evidence requirements on the basis of the benchmarking to the prevision reimbursement decisions of reimbursement authorities and HTA organizations
Countries
14 EU
Availability
On-demand
Why us?
Pharma approach is put aside
Work with a company truly specialized in medical devices and diagnostics. Benefit from our topical knowledge from hundreds of projects
Getting results instantly (reports) or within 4-8 weeks (services)
Make business decisions quickly
17 out of top-30 companies choose MTRC for reimbursement support
Work with a provider who understands the industry’s needs. We served more than 150 clients over the last four years
More than 540 accomplished projects
Work with a provider who has experience in your field. We are ISO 9001:2015 certified and pay a lot of attention to maintain a good quality of services, including >300 internal instructions, regular quality management meetings, strict onboarding and training procedures
Team of 15 full-time employees in 6 countries
Unlike companies with an affiliate model, we do most services with in-house analysts ensuring greater quality, lower cost and predictable outcomes
MTRC is a thought leader in the field of European Med Tech reimbursement
MTRC has unique insights into market access through its various activities, including annual syndicated reports on the topics of HTA, innovation funding, reimbursement of digital health, comprehensive newsletter services, unparalleled educational platform and others
To stay up-to-date, we daily monitor developments of reimbursement systems in Europe
Subscribe to our newsletter to get updates every 2nd week
Only less than 10% of the news is reported in the free-of-charge newsletter. Access our paid services "HTA Alerts" and "Reimbursement Alerts" to get full, customized reports from more than 90 reimbursement and HTA organizations globally. Free first issues of both newsletters are available for download
04 Oct 2022
A value dossier is a document of a certain structure that summarizes in a comprehensive and unbiased way all value-related messages for medical technology. The unique approach of MTRC is based on a deep understanding of evidence and data presentation requirements for market access processes in a large number of European countries.
02
Dec 2022
On November 15, 2022, a new body called “Organization for Outpatient Physician Tariffs AG (OAAT)” was founded under the leadership of the Bernese government councillor. It involves all tariff partners (associations of health insurers curafutura and santésuisse, as well as the association of hospitals H+, the association of physicians FMH, and medical tariff commission MTK/CTM), who have joined forces in order to reach the goal of improving the outpatient reimbursement system.
01
Dec 2022
In November 2022, NHS Accelerated Access Collaborative decided not to add new technologies to MedTech Funding Mandate (MTFM) in 2023/24. Instead, Integrated Care Systems (ICSs) are asked to prioritize the appropriate adoption of currently supported technologies where this has not yet occurred. The MTFM supports eleven NICE-approved and cost-saving devices, diagnostics, and digital products, making them mandatory for implementation and funding.
30
Nov 2022
In November 2022, the National Board of Health and Welfare released the Swedish version of the NordDRG system to come into force in January 2023, including the list of DRG codes, names, and cost-weights. A total of 77 new DRGs will be implemented. Key new DRGs were introduced in cardiovascular, gastrointestinal, and endoscopy fields, also for breast reconstruction and bone-anchored hearing implants.
29
Nov 2022
On November 18, 2022, the Innovation Committee at the Federal Joint Committee (G-BA) announced that sixteen applications for Innovation Funding of the new forms of care were accepted. These applications relate to the funding announcement of March 17, 2021. Most projects relate to interdisciplinary or cross-sectoral care and pathways.
Our two core services are the provision of off-the-shelf and on-demand reimbursement analysis and the development of reimbursement strategy for medical devices in 19 European countries
| Analysis | |
Reimbursement
|
National fundingWillingness to pay for technology, based on:
|
| Strategy |
Reimbursement strategyPathway to get reimbursement:
|
Check our specific propositions for: Med Tech industry, IVD industry, Investors
Our services cover 19 European countries, including Austria, Belgium, Czech Republic, Denmark, England, Finland, France, Germany, Hungary, Italy, the Netherlands, Norway, Poland, Romania, Russia, Spain, Sweden, Switzerland and Turkey
We provide services for major types of medical technologies
|
Implantable devices |
Interventional procedures |
Non-interventional procedures |
In-vitro diagnostic tests |
Medical aids |
|
Our analytical team has worked on hundreds of reimbursement projects within different clinical and technological areas, including heart valve replacement, minimally invasive and open heart surgery, coronary, cerebral and peripheral stenting, coronary diagnostic and imaging techniques (fractional flow reserve, intravascular ultrasound), coronary, cerebral and peripheral vascular thrombectomy, implantable and extracorporeal ventricular assist devices, clinic- and home-based dialysis, extracorporeal membrane oxygenation, apheresis, obesity surgery, hernia and reconstruction surgery, tissue products and skin reconstruction surgery, negative wound pressure therapy and medical bandages, neurostimulators for different indications, cell therapy, rehabilitation devices, devices for minimally invasive and open spine surgery, embolization procedures, glucose monitoring, use of fusidial markers, radiotherapy, endoscopy and more
|
Confidence in results
MTRC is ISO 9001:2015 certified organization (with the United Kingdom Accreditation Service, UKAS). We have established numerous procedures and services to ensure the high relevance and precision of our analysis in order to successfully guide your business decisions:
- Standard Operating Procedures and Work Instructions
- Access to official coding and DRG manuals, tariff lists and grouping software
- A team comprised of experienced Clinical Coders with a medical background
- Quick access to health authorities to address uncertainties
- Ongoing research program to get insights from payer and provider interviews
- All reports are reviewed by the CEO before release
Check out our database of the off-the-shelf reimbursement reports for medical technologies in 11 European countries
Released reports:
|
Ongoing reports:
|